News

Novo Nordisk Shares Rise After FDA Approves Wegovy for Liver Disease

Novo Nordisk shares climbed after the U.S. Food and Drug Administration approved a new indication for the Danish drugmaker’s ...

Mounjaro rivals Wegovy and Retatrutide explained as price hiked for millions of users

Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...
Pharmaceutical Technology50m

Wegovy becomes first GLP-1RA to gain FDA MASH approval

Novo Nordisk's Wegovy has received accelerated approval for use in patients with metabolic dysfunction-associated ...

Shares in Novo Nordisk rise after Wegovy gets US nod for liver disease treatment

By Jacob Gronholt-Pedersen COPENHAGEN, DENMARK (Reuters) -Shares in Novo Nordisk rose on Monday, after it got U.S. approval ...

Patients at risk as Mounjaro price hike sparks panic buying and black-market threat

"This is a real concern for all patients who have been benefiting from this medicine. There will be panic and hysteria out ...
Medical Dialogues9d

Mounjaro, Wegovy sales in India double on month in July

Hyderabad: Sales of weight-loss drugs Wegovy by Danish pharmaceutical giant Novo Nordisk and Mounjaro by U.S.-based Eli Lilly ...

Novo Nordisk's Wegovy gets accelerated US approval for liver disease MASH

Novo Nordisk said on Friday the U.S. Food and Drug Administration has granted accelerated approval for its weight-loss drug ...

Rival fat jab WON’T increase in price, makers pledge – as Mounjaro set to double in costs

MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next ...